Interview with Dino Mangion, Plant Manager, Medichem (Malta)
Medichem began production at its plant in Malta in 2006. Can you give us a brief overview of the facilities, and of the importance of the subsidiary to Corporación Medichem…
Address:
Tel:
Medichem is a Spanish, privately owned company based in Barcelona, engaged in the process development and manufacture of Active Pharmaceutical Ingredients (APIs) for the global pharmaceutical industry since the early 1970s.
Our business model is built around our partners who we aim to please with pro-actively timed, right quality products, carefully avoiding intellectual property infringements. This we can only achieve through the creative thinking of our people, which really is the key to success.
Our partners are principally generic drug companies and pharmaceutical firms worldwide for whom we have developed a strong pipeline of new products that addresses the treatment of diseases in almost all therapeutic areas. We supply them with a wide range of high quality generic and custom manufactured APIs in volumes that range from a few grams to hundreds of tons.
We are a cGMP compliant company with a long and successful history of inspections. This includes regular US-FDA inspections of our plant in Celrà (Girona), Spain since 1985. The last four of these inspections, namely in 1999, 2002, 2006 and April 2009, were “no form 483” rated (no observations were noted).”
Our quality and environmental systems, and working practices supported by the FDA, the ISO 9001 and ISO 14001 certifications, guarantee a consistent follow-up and continuous improvement of our processes.
We have a sister company, Combino Pharm, which has generic formulation, development and manufacturing capabilities, giving us a unique insight for the understanding of the overall generics industry.
We are one of the world’s most respected independent Active Pharmaceutical Ingredients (APIs) suppliers and are headquartered in Barcelona, Spain. Our two manufacturing sites are located in Spain and in Malta. In Spain, we have been regularly inspected by the FDA since 1985, the last four inspections (1999, 2002, 2006 and April 2009) had no “Form 483” issued.
Medichem began production at its plant in Malta in 2006. Can you give us a brief overview of the facilities, and of the importance of the subsidiary to Corporación Medichem…
Ian Restall, general manager at Metallform, explains how he built up the manufacturing plant of the German company in Malta and discusses the future plans to grow the affiliate even…
Marius Calleja, general manager of Maltese contract manufacturer, Starpharma, discusses the company’s current growth strategy and how Starpharma can capitalize on the emergent medical cannabis niche. Even…
Andrew Corrieri, founder and CEO at Pharmaconsulta Ltd, tells the story of how he founded his consultancy, as well as the key expertise he can bring to its clients. Moreover,…
Keith Frendo, plant manager and head quality control of the Maltese service provider Pharmadox, discusses how they are constantly adapting to the needs of their customers by positioning themselves as…
Dr. Josie Muscat, Chairman at Saint James Hospital Group, describes how he founded the only private healthcare group in Malta and led it to its huge success, as well as his…
Mario Galea, CEO of Malta Enterprise, the country’s economic development agency, discusses the importance of Malta’s pharmaceutical manufacturing industry and the country’s strategic positioning at the forefront of medical tourism…
Robert Magri, executive officer for the pharmaceutical division at Alfred Gera & Sons, introduces the key milestones and operations of one of the oldest pharmaceutical distributors in Malta, as well…
Denis Borg, secretary general of the Maltese Italian Chamber of Commerce, discusses the central role of the chamber in developing business between Malta and Italy and explains how Malta’s attractiveness…
Nicholas Falzon and Margot Pisani, respectively president and secretary general at the Pharmaceutical Research-based Industry Malta Association (PRIMA), discuss the business environment for originators in the island as well as…
Paul Apap Bologna, managing director at Associated Drug Company (ADC), introduces his family company, focused on distributing high-quality innovative solutions to Maltese patients, and evokes the key opportunities that the…
Prof. Claude A. Farrugia of the Malta Chamber of Commerce, Enterprise and Industry documents the main trends in the manufacturing industry of Malta and discusses the island’s strengths in discovering…
Alan Camilleri, chairman of Malta Enterprise—the government agency responsible for facilitating and stimulating the development of Malta—recalls the words of a foreign investor, who had taken stake in Maltese…
See our Cookie Privacy Policy Here